Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyaline body myopathy

R J Barohn1, R A Brumback, J R Mendell

  • 1Department of Neurology, University of Texas, Southwestern Medical Center, Dallas.

Neuromuscular Disorders : NMD
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice.

Gene therapy·2015
Same author

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

Gene therapy·2015
Same author

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis.

Neuromuscular disorders : NMD·2013
Same author

Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery.

Molecular therapy : the journal of the American Society of Gene Therapy·2013
Same author

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.

Neurology·2011
Same author

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Brain : a journal of neurology·2009
Same journal

Aquatic training improves muscle strength and functional mobility in adults with myotonic dystrophy type 1: a pilot randomized trial.

Neuromuscular disorders : NMD·2026
Same journal

Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.

Neuromuscular disorders : NMD·2026
Same journal

A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment.

Neuromuscular disorders : NMD·2026
Same journal

Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.

Neuromuscular disorders : NMD·2026
Same journal

Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study.

Neuromuscular disorders : NMD·2026
Same journal

HACD1-related congenital myopathy skeletal muscle MRI findings in a Brazilian cohort.

Neuromuscular disorders : NMD·2026
See all related articles

This study identifies hyaline body myopathy, a rare congenital muscle disease. Muscle biopsies show unique hyaline bodies in type 1 fibers, suggesting a distinct neuromuscular disorder.

Area of Science:

  • Neurology
  • Muscle Physiology
  • Histopathology

Background:

  • Congenital myopathies are a group of inherited muscle disorders presenting in infancy or childhood.
  • Limb weakness since infancy can indicate various neuromuscular conditions requiring precise diagnosis.

Observation:

  • Muscle biopsies from two patients with non-progressive limb weakness revealed subsarcolemmal hyaline bodies.
  • These bodies were found in 20-30% of muscle fibers, exclusively in type 1 fibers.
  • Histochemical stains for oxidative enzymes and PAS were negative, and electron microscopy showed amorphous granular material without a surrounding membrane.

Findings:

  • Hyaline body myopathy is characterized by the presence of unique subsarcolemmal hyaline bodies within type 1 muscle fibers.
  • The amorphous granular material within these bodies has an unknown composition.

Related Experiment Videos

  • The condition exhibits a non-progressive course and childhood onset.

    • Implications:

    • Hyaline body myopathy is proposed as a distinct congenital myopathy based on its unique morphological features and clinical course.
    • Further research into the composition and origin of hyaline bodies is warranted.
    • Accurate diagnosis through muscle biopsy is crucial for understanding and managing this rare myopathy.